Edward Garon

31PUBLICATIONS
214CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 11, 2026
Lessons from Cohort Studies of Targetable Metabolic Deficiencies in Lung Cancer.

|Jul 22, 2026
Utilizing machine learning to identify multimodal signatures for patients who would benefit from the addition of tremelimumab to durvalumab and chemotherapy (TRIDENT).

|Apr 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Jhanelle E Gray, Joel W Neal, Jyoti D Patel

|Apr 06, 2026
Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test.

Weihua Zeng, Chun-Chi Liu, Shuo Li

|Dec 09, 2025
Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma.

Morgan R Brady, Nedas Matulionis, Heather R Christofk

|Sep 10, 2025
Identification of Targetable EGFR Mutations in Ovarian Cancer.

Arjan Gower, Susan Win, Rituparna Ganguly

Pageof 6

Frequent Collaborators

6 joint publications

Aaron Lisberg

6 joint publications

Amy L Cummings

6 joint publications

Shuo Li

5 joint publications

Melissa L Johnson